FHI vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 30, 2026

FHI

51.1
AI Score
VS
FHI Wins

HLNE

43.8
AI Score

Investment Advisor Scores

FHI

51score
Recommendation
HOLD

HLNE

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FHI HLNE Winner
Revenue 478.96M 565.43M HLNE
Net Income 96.38M 183.01M HLNE
Net Margin 20.1% 32.4% HLNE
ROE 8.0% 20.9% HLNE
ROA 4.5% 8.4% HLNE
Total Assets 2.14B 2.17B HLNE
Debt/Equity 0.29 0.32 FHI
Free Cash Flow 24.00M 317.85M HLNE

Relative Price Performance (Last 90 Days)

FHI 1M: +13.0% · 3M: +18.1% HLNE 1M: +19.0% · 3M: +2.5%

Current Technical Phase

FHI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 70

RSI (14): 69.6 · Price: $63.94

HLNE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 71

RSI (14): 71.1 · Price: $94.91

Fundamentals Snapshot

Metric FHI HLNE
Market Cap
Forward P/E 10.9 15.8
Trailing P/E 11.1 15.0
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.4%
EPS 5.38 5.92
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.